Results

Total Results: 8,263 records

Showing results for "topical treatment".

  1. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … For this report, topics that emerged as higher impact focused on treatments for opioid and nicotine … — as do current therapies—but that the monthly visit to a provider for the injection represents a small … About buprenorphine therapy. [internet].
  2. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … No effective treatments are available to improve long-term nutritional absorption other than intestinal … : Overall, experts commenting on this intervention agreed that an unmet need exists for effective treatments
  3. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Overall high-impact potential: Evzio for emergency treatment of opioid overdose by nonclinicians .. … new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Medical treatment would be expected to be sought after administration of Evzio.
  4. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … (Contrave ® , Orexigen Therapeutics, Inc., La Jolla, CA in collaboration with Takeda Pharmaceutical … New drug treatment options are needed for obese patients seeking medical therapy for weight loss. … Goods Administration for inclusion in its therapeutic goods registry for treating T2DM and obesity
  5. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … intervention to these therapies to improve a patient’s chances of successfully quitting. … in this report would compete with shorter-acting oral, sublingual, injectable, or patch-delivered therapies … About buprenorphine therapy. [internet].
  6. integrationacademy.ahrq.gov/news-and-events/calendar
    January 01, 2025 -
  7. Discuss metabolic syndrome, including cause, risk factors, prevention, and treatment options … in part because effective evidence-based treatments for SUDs can be difficult to access in many communities … public health leader with expertise in mental health and justice system reform, before diving into topical
  8. Fewer than 10% of youth in need of substance use treatment receive it, particularly in rural … of readiness, stigma, provider-bias, lack of trust in treatment and treatment not being a priority.
  • www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
    June 01, 2025 - blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment … Ophthalmia Neonatorum: Preventive Medication: newborns The USPSTF recommends prophylactic ocular topical … USPSTF recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy … more information about identification of persons at increased risk and about effective antiretroviral therapy … Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate
  • effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address …  Key Facts: Before the approval of ivacaftor, therapies for CF had improved median survival times … Better treatments to prevent COPD exacerbations are needed. … Although the cost of azithromycin therapy would be additive to current treatment costs, its low cost
  • hcup-us.ahrq.gov/reports/statbriefs/sb24.jsp
    January 01, 2007 - Data Methods Series ICD-10-CM/PCS Resources Database Reports Additional Topics and Archives Topical … or death at a very young age, while others may be successfully treated with surgery or other medical treatments … Hospital utilization and costs for the treatment of birth defects are compared with hospital stays for … Findings In 2004, there were more than 139,000 hospital stays principally for the treatment of birth … The mean age for patients admitted for the treatment of pyloric stenosis, rectal and large intestine
  • www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydial-infection-including-ocular-prophylaxis-screening-1996
    January 01, 1996 - In one study, one fourth of women with positive cultures did not return for therapy. 28 In men, screening … or doxycycline results in a short-term cure in 92-100% of women and 97-100% of men. 1 Single-dose therapy … failures are usually due to failure to treat sex partners, noncompliance with therapy, or reinfection … conjunctivitis, but there is conflicting evidence of the benefit of universal ocular prophylaxis with topical … prevalence of asymptomatic infection, and the availability of reliable screening tests and effective treatments
  • hcup-us.ahrq.gov/reports/statbriefs/sb18.jsp
    May 18, 2016 - Data Methods Series ICD-10-CM/PCS Resources Database Reports Additional Topics and Archives Topical … In 2004, nearly 5 percent of all hospital admissions–about 1.9 million hospitalizations–were for the treatment … The average cost per hospital stay specifically for the treatment of an injury was $2,800 more than the … Hospital costs for injuries, by age and primary payer The mean hospital costs specifically for the treatment
  • effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … 30% of patients achieve overall gout control, so a significant unmet need exists for more effective treatments … could be more expensive than existing options and patients who have trouble affording existing gout treatments
  • effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
    January 01, 2008 - includes hand washing, in-hospital infection control, appropriate antibiotic prescribing, and effective treatment … Date: 6-2-09 2  The literature on this topic indicates that large studies with more standardized treatment … regimens are needed to evaluate the effectiveness of treatments for CDAD.
  • effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Treatment for early intervention includes behavioral and communication therapies (including applied … archived from the horizon scanning system after expert comment processes include hyperbaric oxygen therapy … However, the efficacy of these treatments is unpredictable and varies widely, and when they do work
  • PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … ulcerative colitis), and we continue tracking novel drugs and interventions such as fecal microbiota therapy … No effective treatments are available to improve long-term nutritional absorption other than intestinal … at-home intravenous PN support for SBS, the manufacturer estimates the number of candidates for this therapy
  • hcup-us.ahrq.gov/reports/statbriefs/sb16.jsp
    November 16, 2006 - Data Methods Series ICD-10-CM/PCS Resources Database Reports Additional Topics and Archives Topical … This Statistical Brief presents data from the Healthcare Cost and Utilization Project (HCUP) on the treatment … of influenza in U.S. hospitals in 2004. 2 Hospital utilization and costs for the treatment of influenza … The mean length of stay for the treatment of influenza was 5.3 days�0.7 days longer than for all hospital
  • #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
    October 01, 2014 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … DBS therapy is incompatible with some other device-based depression treatments. … psychotherapy (e.g., counseling), and family intervention as indicated; and considering ECT or alternative therapies … , counseling, family intervention, ECT) will likely remain as complementary therapies to ketamine, … New therapeutic promises in the treatment of depression and schizophrenia.
  • effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
    February 01, 2015 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … We have identified and are currently monitoring multiple potential therapies with these properties, … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central … Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot
  • #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Overall high-impact potential: deep brain stimulation (Reclaim DBS Therapy or Libra DBS) for treatment-resistant … and psychotherapy as first- and second-line therapies and electroconvulsive therapy or repetitive … treatments for treatment-resistant MDD, investigators have sought new approaches because available … DBS therapy is incompatible with some other device-based depression treatments. … Overall high-impact potential: deep brain stimulation (Reclaim DBS Therapy or Libra DBS) for treatment-resistant
  • #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
    January 01, 2012 - Food and Drug Administration has not approved any therapies, is being explored. … third-line therapies for MDD, a proportion of patients affected by MDD have treatment-refractory disease … DBS therapy is incompatible with some other device-based depression treatments. … Menlo Park (CA): Corcept Therapeutics; [accessed 2011 Oct 18]. [2 p]. … Menlo Park (CA): Corcept Therapeutics; [accessed 2011 Oct 18]. [2 p].